AJP - Heart Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 297: H425-H432, 2009. First published May 22, 2009; doi:10.1152/ajpheart.00689.2008
0363-6135/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
297/1/H425    most recent
00689.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Donato, A. J.
Right arrow Articles by Seals, D. R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Donato, A. J.
Right arrow Articles by Seals, D. R.

Vascular endothelial dysfunction with aging: endothelin-1 and endothelial nitric oxide synthase

Anthony J. Donato, Lindsey B. Gano, Iratxe Eskurza, Annemarie E. Silver, Phillip E. Gates, Kristen Jablonski, and Douglas R. Seals

Department of Integrative Physiology, University of Colorado, Boulder, Colorado

Submitted 2 July 2008 ; accepted in final form 19 May 2009

To determine whether impaired endothelium-dependent dilation (EDD) in older adults is associated with changes in the expression of major vasoconstrictor or vasodilator proteins in the vascular endothelium, endothelial cells (EC) were obtained from the brachial artery and peripheral veins of 56 healthy men, aged 18–78 yr. Brachial artery EC endothelin-1 (ET-1) [0.99 ± 0.10 vs. 0.57 ± 0.10 ET-1/human umbilical vein EC (HUVEC) intensity, P = 0.01] and serine 1177 phosphorylated endothelial nitric oxide synthase (PeNOS) (0.77 ± 0.09 vs. 0.44 ± 0.07 PeNOS/HUVEC intensity, P < 0.05) (quantitative immunofluorescence) were greater, and EDD (peak forearm blood flow to intrabrachial acetylcholine) was lower (10.2 ± 0.9 vs. 14.7 ± 1.7 ml·100 ml–1·min–1, P < 0.05) in older (n = 18, 62 ± 1 yr) vs. young (n = 15, 21 ± 1 yr) healthy men. EDD was inversely related to expression of ET-1 (r = –0.39, P < 0.05). Brachial artery EC eNOS expression did not differ significantly with age, but tended to be greater in the older men (young: 0.23 ± 0.03 vs. older: 0.33 ± 0.07 eNOS/HUVEC intensity, P = 0.08). In the sample with venous EC collections, EDD (brachial artery flow-mediated dilation) was lower (3.50 ± 0.44 vs. 7.68 ± 0.43%, P < 0.001), EC ET-1 and PeNOS were greater (P < 0.05), and EC eNOS was not different in older (n = 23, 62 ± 1 yr) vs. young (n = 27, 22 ± 1 yr) men. EDD was inversely related to venous EC ET-1 (r = –0.37, P < 0.05). ET-1 receptor A inhibition with BQ-123 restored 60% of the age-related impairment in carotid artery dilation to acetylcholine in B6D2F1 mice (5–7 mo, n = 8; 30 mo, n = 11; P < 0.05). ET-1 expression is increased in vascular EC of healthy older men and is related to reduced EDD, whereas ET-1 receptor A signaling tonically suppresses EDD in old mice. Neither eNOS nor PeNOS is reduced with aging. Changes in ET-1 expression and bioactivity, but not eNOS, contribute to vascular endothelial dysfunction with aging.

endothelium-dependent dilation; brachial artery flow-mediated dilation



Address for reprint requests and other correspondence: A. J. Donato, Dept. of Integrative Physiology, Univ. of Colorado at Boulder, 354 UCB, Boulder, CO 80309 (e-mail: tony.donato{at}colorado.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.